-
Mashup Score: 1
Dr. Aditya Bardia shared his insights on what he believes are the top side effects to be aware of when undergoing ADC treatment for breast cancer.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0
Elinzanetant significantly reduced the frequency and severity of hot flashes in women with breast cancer who were undergoing hormone therapy.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Feeding Souls: A Cancer Journey Through the Lens of Food - 8 hour(s) ago
I’ve learned that cooking for friends during their cancer journey is a way to express love and support, even if it doesn’t cure them.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 1Symptoms Associated With Polycythemia Vera - 11 hour(s) ago
A panelist discusses how polycythemia vera (PV) symptoms can vary significantly among patients, but commonly include headaches, dizziness, itching (especially after warm baths), fatigue and visual disturbances, with some patients experiencing more severe manifestations like blood clots while others may be relatively asymptomatic.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Rising from Ashes: Rediscovering Myself After Multiple Myeloma - 12 hour(s) ago
I rediscovered myself through community, writing, music and cooking after my journey with multiple myeloma.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Understanding the Concept of MRD for Patients With Cancer - 14 hour(s) ago
Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it relates to recurrence in patients.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 8
Dr. David A Braun delved into detail on the molecular factors driving exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0
Yescarta continued to demonstrate durable responses after a median follow-up of more than five years in patients with R/R indolent non-Hodgkin lymphoma.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 2FDA Approves Datroway for HR+, HER2- Breast Cancer - 17 hour(s) ago
Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 13
Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient access, according to experts.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
Expert Expands on Side Effects Related to ADC Treatment in #BreastCancer @dradityabardia @UCLAHealth @SABCSSanAntonio #SABCS24 #bcsm https://t.co/lUssf09OfV